AstraZeneca’s site serves two distinct audiences with two distinct homepages: a corporate homepage built around science and story for the public, and a separate Investor Relations homepage for analysts and fund managers who need hard numbers fast. As an internal pitch project at VML, I led a redesign of that Investor Relations homepage.
The concept commits to function over form: right angles, no decorative flourishes, full-width strips each doing one job, color used structurally rather than decoratively. The goal was a page an analyst could skim in thirty seconds, but that still rewards a deeper read with real documentation.
